PILOT OF GREEN TEA FOR WEIGHT LOSS
绿茶减肥试点
基本信息
- 批准号:7607172
- 负责人:
- 金额:$ 2.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectBody CompositionBody Weight decreasedCatecholsCholesterolComputer Retrieval of Information on Scientific Projects DatabaseDiseaseDouble-Blind MethodEnergy MetabolismEpigallocatechin GallateFundingGenesGrantGreen teaHumanIndividual DifferencesInstitutionObesityOverweightPatientsPlacebosPurposeRandomizedResearchResearch PersonnelResourcesSerumSourceTransferaseTriglyceridesUnited States Food and Drug AdministrationUnited States National Institutes of HealthWeekWeightdietary supplementsobesity treatmentprescription documentprescription procedurepreventresearch study
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Green tea extract is available without a prescription and is sold as a dietary supplement. It is not approved to prevent or cure any disease and has never been evaluated by the Food and Drug Administration for weight loss or the treatment of obesity. Previous research studies in humans indicate that green tea extracts may help overweight people lose weight. Green tea has not been studied in patients who are obese. The main purpose of this double-blinded, randomized study is to evaluate whether taking a green tea extract results in more weight loss over 18 weeks than taking placebos in obese subjects. The investigators will also study whether green tea extract affects body composition and as energy metabolism. They will also study whether green tea extract can change the levels of serum triglycerides and cholesterol. A secondary purpose of the study is to see if individual differences in a gene called "catechol-o-methyl transferase" are related to weight loss.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JENNIFER L DONOVAN其他文献
JENNIFER L DONOVAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JENNIFER L DONOVAN', 18)}}的其他基金
DRUG INTERACTIONS AND BIOAVAILABILITY OF CRANBERRY FLAVANOIDS
蔓越莓黄酮的药物相互作用和生物利用度
- 批准号:
7719586 - 财政年份:2008
- 资助金额:
$ 2.53万 - 项目类别:
Drug Interactions and Bioavailability of Cranberry
蔓越莓的药物相互作用和生物利用度
- 批准号:
7124417 - 财政年份:2004
- 资助金额:
$ 2.53万 - 项目类别:
Drug Interactions and Bioavailability of Cranberry
蔓越莓的药物相互作用和生物利用度
- 批准号:
6751776 - 财政年份:2004
- 资助金额:
$ 2.53万 - 项目类别:
Drug Interactions and Bioavailability of Cranberry
蔓越莓的药物相互作用和生物利用度
- 批准号:
6842200 - 财政年份:2004
- 资助金额:
$ 2.53万 - 项目类别:
相似海外基金
Understanding causes and consequences of variation in body composition, cardiorespiratory and muscular fitness
了解身体成分、心肺和肌肉健康变化的原因和后果
- 批准号:
MR/Y009398/1 - 财政年份:2024
- 资助金额:
$ 2.53万 - 项目类别:
Fellowship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Effects of daily low oxygen exposure on weight status, body composition, and metabolic health
每日低氧暴露对体重状况、身体成分和代谢健康的影响
- 批准号:
10756039 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
- 批准号:
22KJ2600 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Differential impacts of water insecurity on diet and body composition throughout the life course
水不安全对整个生命过程中饮食和身体成分的不同影响
- 批准号:
10749236 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Oral Feeding Difficulty in Large for Gestational Age Infants: Defining Interrelationships between Body Composition, Oral Feeding Ability, and Appetite-Regulating Hormones
大胎龄婴儿的经口喂养困难:定义身体成分、经口喂养能力和食欲调节激素之间的相互关系
- 批准号:
10734263 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Staging the host in Cancer: AI-based automated comprehensive body composition assessment for Precision Medicine
对癌症宿主进行分期:基于人工智能的自动化综合身体成分评估,用于精准医学
- 批准号:
478392 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Operating Grants
Effects of bimagrumab on body composition, insulin sensitivity, and bone in adults with obesity
bimagrumab 对肥胖成人的身体成分、胰岛素敏感性和骨骼的影响
- 批准号:
10716254 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Relating phthalate and metals exposure during pregnancy and perimenopause to bone health and body composition in midlife
怀孕和围绝经期期间邻苯二甲酸盐和金属暴露与中年骨骼健康和身体成分的关系
- 批准号:
10746972 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别: